| Primary information |
|---|
| ID | antitb_1317 |
| Peptide Name | D-LL37 |
| Sequence | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRN |
| N-terminal Modification | Free |
| C-terminal Modification | Free |
| Chemical Modification | None |
| Linear/ Cyclic | Linear |
| Length | 31 |
| Chirality | D |
| Nature | Cationic |
| Source | Synthetic |
| Origin | NA |
| Species | Mycobacterium tuberculosis |
| Strain | Mycobacterium tuberculosis H37Rv |
| Inhibition Concentartion | MIC = 200 μg/mL |
| In vitro/In vivo | In vitro |
| Cell Line | Human erythrocyte |
| Inhibition Concentartion | NA |
| Cytotoxicity | HC50 = 125 μg/mL |
| In vivo Model | NA |
| Lethal Dose | NA |
| Immune Response | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | NA |
| Other Activities | NA |
| Pubmed ID | 20858205 |
| Year of Publication | 2011 |
| 3-D Structure |  View in Jmol or Download Structure |